Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.

Novo Nordisk Pharma (Taiwan) Ltd. wins the ESG Programme of the Year - Taiwan award at the Healthcare Asia Pharma Awards 2023.

With a strong commitment to defeating diabetes and creating a sustainable future, Novo Nordisk has achieved carbon-neutral manufacturing and implemented various initiatives in this direction. They effectively utilised digital tools to ensure uninterrupted patient care during the COVID-19 pandemic. Novo Nordisk is also actively addressing the obesity problem in Taiwan, collaborating with the National Health Service and societies to make a positive impact. Now, its focus is on sustaining these efforts and reducing its carbon footprint by 50%. Steve Profit, General Manager of Novo Nordisk Taiwan, talks more about this in this interview.

Learn more about them: Novo Nordisk Pharma Taiwan awarded ESG Program of the Year - Taiwan by the Healthcare Asia Pharma Awards

#HealthcareAsiaAwards